Indian Vaccine Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2024-32
                     Indian Vaccine Market 
Research and Forecast 
Report 2024-2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
In ternat ional  Market  Analys is  Research and Consul t ing Group is  a leading adv iser  on management  
s t rategy and market  research wor ldwide.  We par tner  wi th c l ients  in  a l l  regions and indust ry  
vert ica ls  to  ident i fy  thei r  h ighest -value oppor tuni t ies,  address thei r  most  cr i t ica l  chal lenges,  and 
t ransform thei r  bus inesses.
IMARC’s in format ion products  inc lude major market ,  sc ient i f ic ,  economic and technological  
developments  for  bus iness leaders  in  pharmaceut ica l ,  indust r ia l ,  and h igh technology 
organizat ions.  Market  forecasts  and indust ry  analys is  for  b iotechnology,  advanced mater ia ls ,  
chemicals ,  food and beverage,  t ravel  and tour ism, nanotechnology and novel  process ing methods 
are at  the top of  the company’s  exper t ise.
IMARC’s ta i lored approach combines unfathomable ins ight  in to the dynamics o f  companies and 
markets wi th c lose cooperat ion at  a l l  levels  of  the c l ient  organizat ion.  This ensures that  our  c l ients 
achieve unmatchable compet i t ive advantage,  bui ld  more pro f ic ient  organizat ions,  and secure 
las t ing resul ts .
Acco r d ing  t o  t h e  l a t es t  r epo r t  b y  I M ARC  G r oup ,  t i t l e d  " I nd i an  Vacc i ne  M ark e t :  
I ndu st ry  T r ends ,  Sh are ,  S i z e ,  G row t h ,  O pp or t un i t y  and  For ecas t  20 24 -
2032 , "  t he  I nd i an  vacc ine  m a r ke t  s iz e  i s  expe c t ed  t o  exh ib i t  a  g r ow t h  r a t e  ( CAG R)  
o f  1 2 . 3%  du r ing  20 24 - 2 032 .
Report Vacc ine  r e f e r s  t o  a  m e d ic ine  t ha t  a ids  i n  p r o t ec t i ng  aga ins t  h a r m f u l  d i seas es .  I t  u t i l i z es  t he  b ody ’ s  na t u r a l  de f ense s  i n  o r de r  t o  bu i l d  r es i s t an ce  t o  i n f e c t i on s  w h i l e  
m ak ing  t he  i m m u ne  s ys t e m  s t r ong e r .  I t  r eco gn ize s  t he  i nva d ing  f o r e ig n  subs t anc e ,  
Highlight and such  as  t h e  v i r us  o r  bac t e r i a ,  and  p r odu ces  a n t i bod ies  t h a t  ac t  as  a  ba r r i e r  t o  
p r ev en t  t he  i n f ec t i ons .  
I t  i s  w ide l y  ava i l a b le  i n  d i f f e r en t  f o r m s ,  suc h  as  l i qu ids ,  i n j ec t i on  s ho t s ,  n asa l  
Description sp r a ys  an d  p i l l s  t ha t  de f end  t h e  bo dy  a ga ins t  bac t e r i a  an d  v i r u ses .  So m e o f  t he  
com m on ly  u t i l i zed  v acc in es  in c lud e  l i ve - a t t enua t e d ,  i n ac t i va t ed ,  subun i t ,  
r eco m b ina n t ,  po l ys accha r ide ,  and  co n juga t e ,  t oxo id ,  m e sseng e r  r i bonu c le i c  ac id  
( m R NA)  and  v i r a l  ve c t o r  vac c ines .
Reque st  f o r  a  P DF  s ampl e  o f  t h i s  repor t :  
h t t p s : / / www. im ar c g r ou p . com / ind ia n - va cc ine - m ar k e t / r eque s t sam p le
Report Description
I nd i a n  V ac c i ne  M a rke t  T ren ds :
The  I nd ia n  m ar k e t  i s  p r im ar i l y  d r i ven  by  s ign i f i ca n t  g r ow t h  i n  t he  pha r m ac eu t i c a l  i nd us t r y .  A l ong  w i t h  t h i s ,  t he  i nc r eas in g  
i nves t m en t s  b y  p r i va t e  and  pub l i c  f i r m s  f o r  im p r o v ing  t h e  ov e r a l l  ph a r m a ceu t i ca l  i n f r as t r uc t u r e  i s  c r ea t in g  a  p os i t i v e  
m ar k e t  ou t l oo k .  M or eove r ,  t he  g r ow in g  p r eva lence  o f  l i f e - t h r ea t en in g  d i seas es ,  such  as  t he  r ap i d  ou t b r ea k  o f  co r on av i r us  
d i seas e  ( CO V I D- 1 9 ) ,  has  p r ov id ed  a  bo os t  t o  t he  dem a nd  f o r  v acc in es  ac r o ss  t h e  c oun t r y .  Add i t i o na l l y ,  num er o us  
i n i t i a t i ves  u nde r t aken  by  t he  gove r nm e n t  o f  I n d ia  t o  adm in i s t e r  va cc ine s  t o  r u r a l  an d  und e r se r ved  a r eas  a r e  im p ac t i n g  
t he  m ar k e t  g r ow t h  f avo r ab l y .  
Fu r t h e r m o r e ,  ex t e ns i ve  r esea r ch  a nd  dev e lopm en t  ( R &D)  a c t i v i t ie s  con duc t e d  by  ke y  p laye r s  f o r  vacc ine  de ve lopm en t ,  
a r e  s uppo r t i ng  t h e  I nd ian  vac c ine  i nd us t r y  t o  g r ow  s ig n i f i ca n t l y .  T he  m ar ke t  i s  f u r t he r  d r i ven  by  co n t i nu a l  t echn o log i ca l  
advan cem en t s  i n  p r o duc t i on  p r oc esses  a nd  t he  ad ven t  o f  im p r ov ed  co ld  s t o r age  f a c i l i t i es .  O t he r  f a c t o r s ,  i n c lud in g  
con t in uous  im pr ov em e n t s  i n  t he  h ea l t h ca r e  se c t o r ,  t he  r i s i ng  a war en ess  am ong  t he  m asse s ,  l o w  cos t  o f  p r odu c t i on ,  
con t in ua l  deve l opm en t s  i n  t h e  s upp ly  cha in  an d  d i s t r i bu t i on  ch anne ls ,  an d  t he  in c r ea s ing  n um b er  o f  r esea r ch  l abo r a t o r i es  
and  c l i n i ca l  cen t e r s ,  a r e  a l so  pos i t i ve l y  i n f l uen c ing  t he  m ar k e t  ac r oss  I nd ia .
Vi ew  Repo r t  T O C,  F i g ures  and  T ab l e s :  h t t ps : / / w w w . i mar cgrou p . com / i n d i an - vacc i ne - mark e t
Breakup by Monovalent and Combined 
Vaccines:
• BCG 
• HIB 
• Infl uenza 
• Varicel la 
Report • Typhoid 
• Japanese Encephal i t is
Segmentation • Measles 
• Tetanus Toxoid 
• Hepatit is  A 
• Rubel la 
• Diphther ia 
• Tetanus, and Pertussis (DPT) 
• Oral Pol io Vaccine (OPV) 
• MMR
• Rotavirus 
• Hepatit is B 
• Pneumococcal  
Report • Meningococcal  
• Rabies
Segmentation
• HPV
• Hexavalent
• Dengue vaccines
• GlaxoSmithKl ine
• Sanofi  Aventis
• Serum Inst itute of India
• Panacea Biotec
Competitive 
• Pfi zer
Landscape • Novart is
with Key • VHB Lifesciences
•
Players Zydus Cadi la
• MSD.
What is the expected growth rate of the Indian 
vaccine market during 2024-2032?
What are the key factors driving the Indian vaccine 
market?
Key What has been the impact of COVID-19 on the Indian vaccine market?
Questions 
What is the breakup of the Indian vaccine market 
based on the monovalent and combined vaccines?
Answered in 
the Report Who are the key players/companies in the Indian vaccine market?
1     P r e f a c e
2     S c o p e  a n d  M e t h o d o l o g y
    2 . 1     O b j e c t i v e s  o f  t h e  S t u d y
    2 . 2     S t a k e h o l d e r s
    2 . 3     D a t a  S o u r c e s
        2 . 3 . 1     P r i m a r y  S o u r c e s
        2 . 3 . 2     S e c o n d a r y  S o u r c e s
    2 . 4     M a r k e t  E s t i m a t i o n
Table of         2 . 4 . 1     B o t t o m - U p  A p p r o a c h        2 . 4 . 2     T o p - D o w n  A p p r o a c h
    2 . 5     F o r e c a s t i n g  M e t h o d o l o g y
3     E x e c u t i v e  S u m m a r y
4     I n t r o d u c t i o n
Contents     4 . 1     O v e r v i e w    4 . 2     K e y  I n d u s t r y  T r e n d s
5     I n d i a n  V a c c i n e  I n d u s t r y
    5 . 1  M a r k e t  O v e r v i e w
    5 . 2  M a r k e t  P e r f o r m a n c e
        5 . 2 . 1  V o l u m e  T r e n d s
        5 . 2 . 2  V a l u e  T r e n d s
    5 . 3  I m p a c t  o f  C O V I D - 1 9
    5 . 4  M a r k e t  B r e a k u p  b y  S e g m e n t
    5 . 5  M a r k e t  F o r e c a s t
        5 . 5 . 1  V o l u m e  T r e n d s
        5 . 5 . 2  V a l u e  T r e n d s
6    M a r k e t  A n a l y s i s  o f  V a r i o u s  M o n o v a l e n t  a n d  C o m b i n e d  V a c c i n e s
    6 . 1  B C G  V a c c i n e  M a r k e t
        6 . 1 . 1  V a c c i n e  O v e r v i e w
        6 . 1 . 2  M a r k e t  P e r f o r m a n c e
       
        6 . 1 . 3  M a r k e t  B r e a k u p  b y  P r e s c r i b e r
        6 . 1 . 4  M a r k e t  B r e a k u p  b y  P u b l i c  a n d  P r i v a t e  S e c t o r
        6 . 1 . 5  M a r k e t  F o r e c a s t
    6 . 2  H I B  V a c c i n e  M a r k e t
        6 . 2 . 1  V a c c i n e  O v e r v i e w
        6 . 2 . 2  M a r k e t  P e r f o r m a n c e
        6 . 2 . 3  M a r k e t  B r e a k u p  b y  P r e s c r i b e r
        6 . 2 . 4  M a r k e t  B r e a k u p  b y  P u b l i c  a n d  P r i v a t e  S e c t o r
        6 . 2 . 5  M a r k e t  F o r e c a s t
Table of     6 . 3  I n f l u e n z a  V a c c i n e  M a r k e t        6 . 3 . 1  V a c c i n e  O v e r v i e w
        6 . 3 . 2  M a r k e t  P e r f o r m a n c e
        6 . 3 . 3  M a r k e t  B r e a k u p  b y  P r e s c r i b e r
Contents         6 . 3 . 4  M a r k e t  B r e a k u p  b y  P u b l i c  a n d  P r i v a t e  S e c t o r        6 . 3 . 5  M a r k e t  F o r e c a s t
    6 . 4  V a r i c e l l a  V a c c i n e  M a r k e t
        6 . 4 . 1  V a c c i n e  O v e r v i e w
        6 . 4 . 2  M a r k e t  P e r f o r m a n c e
        6 . 4 . 3  M a r k e t  B r e a k u p  b y  P r e s c r i b e r
        6 . 4 . 4  M a r k e t  B r e a k u p  b y  P u b l i c  a n d  P r i v a t e  S e c t o r
        6 . 4 . 5  M a r k e t  F o r e c a s t
    6 . 5  T y p h o i d  V a c c i n e  M a r k e t
        6 . 5 . 1  V a c c i n e  O v e r v i e w
        6 . 5 . 2  M a r k e t  P e r f o r m a n c e
        6 . 5 . 3  M a r k e t  B r e a k u p  b y  P r e s c r i b e r
        6 . 5 . 4  M a r k e t  B r e a k u p  b y  P u b l i c  a n d  P r i v a t e  S e c t o r
        6 . 5 . 5  M a r k e t  F o r e c a s t
F o r  m o r e  i n f o r m a t i o n ,  v i s i t :  
ht t ps : / /w ww. i ma rc gro up . c o m / i n d i a n -v a c c in e -m a rke t / t o c
Disclaimer
© 2023  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
TELEPHONE: +1-631-791-1145 
E-MAIL: [email protected]